Back to BlackRock, Inc. BlackRock, Inc.

AMRXAMRX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AMNEAL PHARMACEUTICALS INC

BlackRock, Inc. holds 26.6M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $459.8M as of 2026-Q2. The position was increased (+8.3% shares). AMRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$459.8M

Current Shares

26.6M

Total Value Change

+$360.1M

Total Shares Change

+14M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
26.6M
+8.3%
$459.8M0.0%$17.31
34
2026-Q1
Increased
24.5M
+71.5%
$304.8M0.0%$13.31
46
2025-Q4
Increased
14.3M
+1.6%
$180.2M0.0%$12.88
31
2025-Q3
Increased
14.1M
+16.0%
$140.9M0.0%$9.87
35
2025-Q2
Decreased
12.1M
-3.6%
$98.1M0.0%$8.13
0
2025-Q1
Decreased
12.6M
0.0%
$105.5M0.0%$8.28
0
2024-Q4
New
12.6M
-
$99.7M0.0%$7.83
41

Other major holders of AMRX: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used